Why is it so hard to speak out about patient safety?
In the previous episodes of Doctor Informed, we've heard why it's so important to talk about patient safety concerns, and some of the mechanisms that allow hospital staff to raise them, but knowing why and how doesn't always make it easier to speak out.
In this episode we're exploring the concept of a voiceable concern – identifying what counts as a concern, and what counts as an occasion for voice by an individual, is not a straightforward matter of applying objective criteria- for example how do you tell if you're witnessing poor practice, or just something that lies outside your area of understanding? Or how do you ...
Source: The BMJ Podcast - January 21, 2022 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Why is it so hard to speak out about patient safety?
In the previous episodes of Doctor Informed, we've heard why it's so important to talk about patient safety concerns, and some of the mechanisms that allow hospital staff to raise them, but knowing why and how doesn't always make it easier to speak out.
In this episode we're exploring the concept of a voiceable concern – identifying what counts as a concern, and what counts as an occasion for voice by an individual, is not a straightforward matter of applying objective criteria- for example how do you tell if you're witnessing poor practice, or just something that lies outside your area of understanding? Or how do you ...
Source: The BMJ Podcast - January 21, 2022 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Have we misunderstood TB's timeline?
The number of people estimated to be latently infected with TB - that is infected with TB, which has not yet manifested symptoms - is around 2 billion. That is 1 in 3 people on the planet are infected by the bacteria. The World Health Organization ’s website notes that on average 5-10% of those infected with TB will develop active TB.
That number is terrifying, but a new analysis published in the BMJ, suggests that the assumption that latent TB often has a very long incubation period of many years may be wrong - and that may change how we calculate the number of people affected, and our whole approach to tackling the di...
Source: The BMJ Podcast - August 23, 2018 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Have we misunderstood TB ’s timeline?
The number of people estimated to be latently infected with TB - that is infected with TB, which has not yet manifested symptoms - is around 2 billion. That is 1 in 3 people on the planet are infected by the bacteria. The World Health Organization’s website notes that on average 5-10% of those infected with TB will develop active TB.
That number is terrifying, but a new analysis published in the BMJ, suggests that the assumption that latent TB often has a very long incubation period of many years may be wrong - and that may change how we calculate the number of people affected, and our whole approach to tackling the dis...
Source: The BMJ Podcast - August 23, 2018 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Evolving management of relapsed CLL: UK CLL Forum analysis of ibrutinib at first relapse
There are an array of new strategies evolving to manage relapsed chronic lymphocytic leukemia (CLL). In this interview, George Follows, MA, BM, BCh, PhD, FRCP, FRCPath, from Cambridge University Hospi...
Author: VJHemOnc
Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Timing of Key Genetic Events In Renal Cancer and Possible Prevention Strategies
Tom Mitchell BMBCh, DPhil, FRCS, Academic Clinical Lecturer & Honorary Urology Registrar, Cambridge University Hospitals discusses Timing of Key Genetic Events In Renal Cancer and Possible Prevention ...
Author: kidneycancer
Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Telephone consultations - no cost savings, but increased GP workload
If you're a patient in the UK, increasingly, your first interaction with the healthcare system won't be the traditional face to fact chat with your doctor - instead you'll have a telephone consultation.
The prevalence of these telephone consultations is increasing, and being promoted by CCGs and private companies who administer them - usually as a cost saving measure.
Now new research published on bmj.com looks at these phone consultation - how often they happen, how patients feel about them, an d how much money they actually save.
In this podcast we're joined by Martin Roland, emeritus professor of health services res...
Source: The BMJ Podcast - September 28, 2017 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Telephone consultations - no cost savings, but increased GP workload
If you're a patient in the UK, increasingly, your first interaction with the healthcare system won't be the traditional face to fact chat with your doctor - instead you'll have a telephone consultation.
The prevalence of these telephone consultations is increasing, and being promoted by CCGs and private companies who administer them - usually as a cost saving measure.
Now new research published on bmj.com looks at these phone consultation - how often they happen, how patients feel about them, and how much money they actually save.
In this podcast we're joined by Martin Roland, emeritus professor of health services resea...
Source: The BMJ Podcast - September 28, 2017 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Are combination therapies the future of renal cell carcinoma treatment?
Grant Stewart, MBChB, FRCSEd (Urol), PhD, from the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, discusses novel treatments for renal cell carcinoma (...
Author: VJOncology
Added: 05/09/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 9, 2017 Category: Cancer & Oncology Source Type: podcasts
A positive review of current and future chronic lymphocytic leukemia treatments
George Follows, MA, BM, BCh, PhD, FRCP, FRCPath from Cambridge University, Cambridge, UK provides us with an update on current and future chronic lymphocytic leukemia (CLL) treatments that have been p...
Author: PatientPowerEU
Added: 02/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 20, 2017 Category: Cancer & Oncology Source Type: podcasts
Late effects of anticancer chemotherapy: It's hard to trust your body, after it's betrayed you
Lily was diagnosed at 14 years old with stage four Hodgkin's lymphoma and received six rounds of chemotherapy and two weeks of radiotherapy. She survived but now lives with the long term effects of that therapy - and joins us to discuss how it has impacted her quality of life.
We're also joined by Saif Ahmad and Thankamma Ajithkumar, oncologists from Cambridge University Hospitals NHS Foundation Trust, who give advice for generalists on late effects of anticancer chemotherapy that may affect quality of life.
Read the full clinical review:
http://www.bmj.com/content/354/bmj.i4567 (Source: The BMJ Podcast)
Source: The BMJ Podcast - September 8, 2016 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Late effects of anticancer chemotherapy: It ’s hard to trust your body, after it’s betrayed you
Lily was diagnosed at 14 years old with stage four Hodgkin's lymphoma and received six rounds of chemotherapy and two weeks of radiotherapy. She survived but now lives with the long term effects of that therapy - and joins us to discuss how it has impacted her quality of life.
We're also joined by Saif Ahmad and Thankamma Ajithkumar, oncologists from Cambridge University Hospitals NHS Foundation Trust, who give advice for generalists on late effects of anticancer chemotherapy that may affect quality of life.
Read the full clinical review:
http://www.bmj.com/content/354/bmj.i4567 (Source: The BMJ Podcast)
Source: The BMJ Podcast - September 8, 2016 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Overview of new therapies in CLL presented at ASH 2015
George Follows, MA, PhD, MRCP, FRCPath from Cambridge University Hospital, Cambridge, UK, gives an overview of the new chronic lymphocytic leukemia (CLL) treatments being presented at the American Soc...
Author: PatientPowerEU
Added: 01/08/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 8, 2016 Category: Cancer & Oncology Source Type: podcasts
Gwyn Stafford, Specialist Nurse, discusses infections in CLL
Gwyneth Stafford CLL & Lymphoma Nurse Specialist at Cambridge University Hospitals gives her perspective on the challenges that CLL patients experience when managing infections.
Author: PatientPowerEU
Added: 02/06/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2015 Category: Cancer & Oncology Source Type: podcasts
Dr George Follows at ASH 2014: Latest developments in CLL
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr George Follows (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) discusses the management of patients with chroni...
Author: PatientPowerEU
Added: 01/29/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2015 Category: Cancer & Oncology Source Type: podcasts
